Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...
The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just dozens, but thousands of patients. However, translating brilliant science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback